Literature DB >> 19107418

Performing in vitro sumoylation reactions using recombinant enzymes.

Andreas Werner1, Marie-Christine Moutty, Ulrike Möller, Frauke Melchior.   

Abstract

Sumoylation of proteins in vitro has evolved as an indispensable tool for the functional analysis of this post-translational modification. In this article we present detailed protocols for bacterial production of mammalian proteins necessary to perform in vitro sumoylation reactions, namely the E1 activating enzyme Aos1/Uba2 (SAE1/SAE2), the E2 conjugating enzyme Ubc9, SUMO-1 (identical protocols can be used for SUMO-2/3), and the catalytic domain of the E3 ligase RanBP2/Nup358. Two alternative procedures are described for the E1 enzyme, one depending on co-expression of His-Aos1 and untagged Uba2, and a second protocol for separate expression of His-Aos1 and Uba2-His and subsequent reconstitution of the active dimer. Two example conditions for in vitro sumoylation of RanGAP1 and Sp100 in the absence or presence of the SUMO E3 ligase RanBP2, respectively, are provided. Both protocols can be adapted easily to test in vitro conjugation of other target proteins and/or E3 ligases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19107418     DOI: 10.1007/978-1-59745-566-4_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.

Authors:  Volkan Sakin; Sebastian M Richter; He-Hsuan Hsiao; Henning Urlaub; Frauke Melchior
Journal:  J Biol Chem       Date:  2015-08-06       Impact factor: 5.157

2.  In vitro assay to determine SUMOylation sites on protein substrates.

Authors:  Francis P McManus; Christine Desroches Altamirano; Pierre Thibault
Journal:  Nat Protoc       Date:  2016-01-28       Impact factor: 13.491

3.  In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation.

Authors:  Jiwon Hwang; Robert F Kalejta
Journal:  Methods       Date:  2011-07-24       Impact factor: 3.608

4.  "ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides.

Authors:  He-Hsuan Hsiao; Erik Meulmeester; Benedikt T C Frank; Frauke Melchior; Henning Urlaub
Journal:  Mol Cell Proteomics       Date:  2009-08-31       Impact factor: 5.911

5.  Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions.

Authors:  Sarah Schulz; Georgia Chachami; Lukasz Kozaczkiewicz; Ulrike Winter; Nicolas Stankovic-Valentin; Petra Haas; Kay Hofmann; Henning Urlaub; Huib Ovaa; Joachim Wittbrodt; Erik Meulmeester; Frauke Melchior
Journal:  EMBO Rep       Date:  2012-08-10       Impact factor: 8.807

6.  Detection of protein SUMOylation in vivo.

Authors:  Michael H Tatham; Manuel S Rodriguez; Dimitris P Xirodimas; Ronald T Hay
Journal:  Nat Protoc       Date:  2009-09-03       Impact factor: 13.491

7.  E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.

Authors:  Christopher T Coey; Megan E Fitzgerald; Atanu Maiti; Katherine H Reiter; Catherine M Guzzo; Michael J Matunis; Alexander C Drohat
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

8.  SUMOylation regulates the homologous to E6-AP carboxyl terminus (HECT) ubiquitin ligase Rsp5p.

Authors:  Tatiana Vladislavovna Novoselova; Ruth-Sarah Rose; Helen Margaret Marks; James Andrew Sullivan
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

9.  Choreography of importin-α/CAS complex assembly and disassembly at nuclear pores.

Authors:  Changxia Sun; Guo Fu; Danguole Ciziene; Murray Stewart; Siegfried M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

10.  SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.

Authors:  An-Jing Chen; Lu Gao; Xian-Wei Wang; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.